FDA warns against using compounded semaglutideThe FDA has received adverse event reports after patients used compounded semaglutide for type 2 diabetes and weight loss. Drug...
GLP-1s associated with higher risk of major depression, increased risk for anxiety and an elevated risk for suicidal behaviour1 day ago
